Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-12-16-Speech-2-263"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-12-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Medicinal products2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20031216.6.2-263"2
lpv:hasSubsequent	lp_eu:2003-12-16-Speech-2-2642
lpv:speaker	lp:Johannes Blokland2
lpv:spokenAs	unknown; ChristenUnie - Staatkundig Gereformeerde Parti (2002-03-18--2004-07-19)3 member; Delegation to the European Economic Area Joint Parliamentary Committee (EEA) (2002-02-07--2004-07-19)3 member; ECON (2002-01-17--2004-07-19)3 vice-chair; Delegation to the EU-Slovak Republic Joint Parliamentary Committee (2002-02-07--2004-04-30)3 co-chair; EDD (2001-01-30--2004-07-19)3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3
lpv:translated text	"Mr President, I, too, wish to thank the rapporteurs and the Commissioner. Nevertheless, I still take issue with two points: patent protection and homeopathic medicinal products. In May, ten countries will be joining the European Union. Naturally, they are most welcome; at least that is what we tell them. Of course, saying and doing are two different things. That is also evident today: the proposals that the Commission and the Council have made here can hardly be called a warm welcome. For one thing, the compromise on patent protection is extremely disadvantageous for the new Member States. In the accession negotiations, it was agreed with these countries that they would include a protection period of six years in their legislation. The ‘8 + 2 + 1’ compromise would mean health care in these countries becoming much more expensive: to the tune of hundreds of millions a year. Commissioner Liikanen may well promise a transitional period, and I welcome that in itself, but it is less than was agreed. Amendment No 55, which I and my colleague Mrs Corbey have tabled and which has the support of a large number of observers, returns to the new Member States what they were promised, thus translating our good words into good deeds. A second point is that the compromise proposal on the table also pays particularly scant regard to homeopathic medicinal products, even though a substantial majority in the Committee on the Environment, Public Health and Consumer Policy did advocate this. One hundred and ten million Europeans use these medicinal products, and we must not deny them this. I therefore call on my fellow Members to support Amendment Nos 20, 21, 22, 23 and 38."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph